Showing results (221-230 of 332) with videos related to
Sort By:
Pageof 34
The New England Journal of Medicine|September 15, 2016
Rituximab in B-Lineage Adult Acute Lymphoblastic LeukemiaSébastien Maury, Sylvie Chevret, Xavier Thomas, et al.Bone Marrow Transplantation|February 17, 2019
Evaluation of infectious complications after haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide following reduced-intensity and myeloablative conditioning: a study on behalf of the Francophone Society of Stem Cell Transplantation and Cellular Therapy (SFGM-TC)Amandine Fayard, Elisabeth Daguenet, Didier Blaise, et al.Bone Marrow Transplantation|October 31, 2019
Influence of alternative donor type on early survival after hematopoietic stem cell transplantation for acute myeloid leukemia lacking a sibling donorClémence Deteix, Florence Mesnil, Sabine Furst, et al.Blood|September 10, 2015
Outcome of patients with distinct molecular genotypes and cytogenetically normal AML after allogeneic transplantationChristoph Schmid, Myriam Labopin, Gerard Socié, et al.Annals of Hematology|June 22, 2020
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TCAmandine Le Bourgeois, Myriam Labopin, Ambroise Marçais, et al.International Journal of Laboratory Hematology|September 14, 2024
Deep Learning-Based Blood Abnormalities Detection as a Tool for VEXAS Syndrome ScreeningCédric De Almeida Braga, Maxence Bauvais, Pierre Sujobert, et al.Eclinicalmedicine|April 12, 2021
A randomised, placebo-controlled phase 3 study to evaluate the efficacy and safety of ASP0113, a DNA-based CMV vaccine, in seropositive allogeneic haematopoietic cell transplant recipientsPer Ljungman, Arancha Bermudez, Aaron C Logan, et al.Cancer|October 29, 2020
Post-transplantation cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation from HLA-identical sibling donors: A retrospective analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationGiorgia Battipaglia, Myriam Labopin, Rose-Marie Hamladji, et al.Blood Advances|March 1, 2024
Haploidentical stem cell donor choice for patients with acute myeloid leukemia: a study from the ALWP of the EBMTJaime Sanz, Myriam Labopin, Didier Blaise, et al.Cancer Medicine|December 28, 2020
A new cytokine-based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemiaPierre Peterlin, Joelle Gaschet, Thierry Guillaume, et al.Pageof 34